Extracellular pro-inflammatory substrates

Extracellular pro-inflammatory substrates represent a broad and diverse class of signaling molecules, including cytokines, chemokines, and damage-associated molecular patterns (DAMPs), that are released into the extracellular environment to initiate and amplify the immune response (Kessel et al., 2021). These molecules, such as Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-1 beta (IL-1β), serve as critical ligands that bind to specific transmembrane receptors on target cells, triggering downstream pathways like NF-κB and MAPK to promote inflammation (Dinarello, 2018). While essential for host defense against pathogens and injury, the chronic or excessive accumulation of these substrates in the extracellular space is a primary driver of tissue damage in autoimmune and autoinflammatory diseases (Roh & Sohn, 2018). Therapeutic intervention typically involves the use of biologic agents, such as monoclonal antibodies or decoy receptors, designed to sequester and neutralize these substrates before they can engage their cellular receptors (StatPearls, 2023). Because these substrates are integral to normal immune surveillance, their systemic inhibition carries significant safety risks, most notably an increased susceptibility to opportunistic infections.

Other names

Pro-inflammatory mediatorsInflammatory secretomeExtracellular inflammatory ligandsPro-inflammatory cytokines and chemokinesInflammatory humoral factors

Neutralization of extracellular ligands via monoclonal antibodies or soluble decoy receptors to prevent binding to cognate cell-surface receptors and subsequent intracellular signal transduction cascades.